[ORGANIZATION]
Imdelltra
Featured in 3 tracked stories · first seen
Situations
ESMO 2026 oncology congress developments
4 clusters · 89 sources · last updated
Latest: ESMO 2026: New cancer therapies presented in Madrid
The European Society for Medical Oncology (ESMO) 2026 congress in Madrid presented various phase 3 clinical trial results across multiple cancer types. Initial reports highlighted advancements in melanoma, where combini
ES-SCLC combination therapy clinical trial results
3 clusters · 23 sources · last updated
Latest: Dual immunotherapy improves survival for small cell lung cancer patients
Results from the Phase 3 DeLLphi-305 clinical trial indicate that a combination of Amgen’s Imdelltra (tarlatamab) and AstraZeneca’s Imfinzi (durvalumab) significantly improves survival outcomes for patients with extensiv
Also covered in
-
FDA reduces monitoring time for Imdelltra's first two doses
[HEALTH] · 2 sources ·